News about "Community-Acquired Bacterial Pneumonia "

Dr. Jitendra Singh Announces Soft Launch of Antibiotic Nafithromycin

Dr. Jitendra Singh Announces Soft Launch of  Antibiotic Nafithromycin

The antibiotic ‘Nafithromycin’ has been developed with the support of Biotechnology Industry Research Assistance Council (BIRAC), a unit of the Department of Biotechnology and has been brought to market under the trade name ‘Miqnaf’ by pharma company ‘Wolkardt’.

Community-Acquired Bacterial Pneumonia | 22/11/2024 | By Aishwarya 833


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members